Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthias Briel

Showing results (221-230 of 288) with videos related to

Pageof 29
Sort By:
Lancet (London, England)|January 23, 2015
Adjunct prednisone therapy for patients with community-acquired pneumonia: a multicentre, double-blind, randomised, placebo-controlled trialClaudine Angela Blum, Nicole Nigro, Matthias Briel, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 2, 2022
Antibody Response in Immunocompromised Patients After the Administration of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Vaccine BNT162b2 or mRNA-1273: A Randomized Controlled TrialBenjamin Speich, Frédérique Chammartin, Irene A Abela, et al.
Journal of Clinical Epidemiology|November 12, 2016
Randomized trials addressing a similar question are commonly published after a trial stopped early for benefitM Hassan Murad, Gordon H Guyatt, Juan Pablo Domecq, et al.
BMJ Open|April 20, 2026
Linezolid in addition to standard antibiotic treatment for <i>Staphylococcus aureus</i> bacteraemia: study protocol for a randomised, placebo-controlled trialNatalie Rose, Nadine S Bernasconi, Michaela Schumacher, et al.
BMJ Open|December 18, 2020
Reporting of methodological studies in health research: a protocol for the development of the MethodologIcal STudy reportIng Checklist (MISTIC)Daeria O Lawson, Livia Puljak, Dawid Pieper, et al.
Trials|October 24, 2023
Community-based type 2 diabetes care by lay village health workers in rural Lesotho: protocol for a cluster-randomized trial within the ComBaCaL cohort study (ComBaCaL T2D TwiC)Felix Gerber, Ravi Gupta, Thabo Ishmael Lejone, et al.
Systematic Reviews|November 27, 2014
Impact of missing participant data for dichotomous outcomes on pooled effect estimates in systematic reviews: a protocol for a methodological studyElie A Akl, Lara A Kahale, Arnav Agarwal, et al.
Journal of Clinical Epidemiology|January 26, 2013
Randomized trials published in higher vs. lower impact journals differ in design, conduct, and analysisMalgorzata M Bala, Elie A Akl, Xin Sun, et al.
BMJ (Clinical Research Ed.)|May 22, 2012
Potential impact on estimated treatment effects of information lost to follow-up in randomised controlled trials (LOST-IT): systematic reviewElie A Akl, Matthias Briel, John J You, et al.
Trials|September 9, 2025
Who is in your trial? Improving the reporting of participant characteristics in trial protocols and resultsShaun Treweek, Shoba Dawson, Kamlesh Khunti, et al.
Pageof 29

Showing results (221-230 of 288) with videos related to

Sort By:
Pageof 29
Lancet (London, England)|January 23, 2015
Adjunct prednisone therapy for patients with community-acquired pneumonia: a multicentre, double-blind, randomised, placebo-controlled trialClaudine Angela Blum, Nicole Nigro, Matthias Briel, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 2, 2022
Antibody Response in Immunocompromised Patients After the Administration of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Vaccine BNT162b2 or mRNA-1273: A Randomized Controlled TrialBenjamin Speich, Frédérique Chammartin, Irene A Abela, et al.
Journal of Clinical Epidemiology|November 12, 2016
Randomized trials addressing a similar question are commonly published after a trial stopped early for benefitM Hassan Murad, Gordon H Guyatt, Juan Pablo Domecq, et al.
BMJ Open|April 20, 2026
Linezolid in addition to standard antibiotic treatment for <i>Staphylococcus aureus</i> bacteraemia: study protocol for a randomised, placebo-controlled trialNatalie Rose, Nadine S Bernasconi, Michaela Schumacher, et al.
BMJ Open|December 18, 2020
Reporting of methodological studies in health research: a protocol for the development of the MethodologIcal STudy reportIng Checklist (MISTIC)Daeria O Lawson, Livia Puljak, Dawid Pieper, et al.
Trials|October 24, 2023
Community-based type 2 diabetes care by lay village health workers in rural Lesotho: protocol for a cluster-randomized trial within the ComBaCaL cohort study (ComBaCaL T2D TwiC)Felix Gerber, Ravi Gupta, Thabo Ishmael Lejone, et al.
Systematic Reviews|November 27, 2014
Impact of missing participant data for dichotomous outcomes on pooled effect estimates in systematic reviews: a protocol for a methodological studyElie A Akl, Lara A Kahale, Arnav Agarwal, et al.
Journal of Clinical Epidemiology|January 26, 2013
Randomized trials published in higher vs. lower impact journals differ in design, conduct, and analysisMalgorzata M Bala, Elie A Akl, Xin Sun, et al.
BMJ (Clinical Research Ed.)|May 22, 2012
Potential impact on estimated treatment effects of information lost to follow-up in randomised controlled trials (LOST-IT): systematic reviewElie A Akl, Matthias Briel, John J You, et al.
Trials|September 9, 2025
Who is in your trial? Improving the reporting of participant characteristics in trial protocols and resultsShaun Treweek, Shoba Dawson, Kamlesh Khunti, et al.
Pageof 29